Zitong Feng

Zitong Feng

Auto-generated profile, based on publicly available information

Zitong Feng

Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
ZFZitong Feng
Zitong Feng
JYJuan Yang
Juan Yang
MXMIngzhu Xu
MIngzhu Xu
RLRun Lin
Run Lin
HYHuijun Yang
Huijun Yang
SCShaoyang Cui
Shaoyang Cui

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
RLRun Lin
Run Lin
SCShaoyang Cui
Shaoyang Cui
JYJuan Yang
Juan Yang
HYHuijun Yang
Huijun Yang
ZFZitong Feng
Zitong Feng
MXMIngzhu Xu
MIngzhu Xu
Background and Purpose. Mild cognitive impairment (MCI) is a common condition, which threatens the quality of life of older adults. Tai Chi (TC) is growing in popularity among patients with MCI. This study is aimed at evaluating the effectiveness and safety of TC in older adults with MCI. Design. Randomized controlled trials (RCTs) from multiple databases from inception to December 2020 published in English were searched. Two researchers independently performed eligible study screening and data extraction. The methodological quality was assessed with the Jadad score. Meta‐analysis of RCTs on TC in the treatment of MCI was performed with RevMan Version 5.4.1. Results. Seven RCTs with 1265 participants were included. For most RCTs, the overall reporting of methodological quality was high. Results of the meta‐analysis indicate that TC improved MCI patients’ cognitive function significantly, including overall cognitive function (MD = −2.24, 95% CI ‐3.51 to ‐0.97, P = 0.0005), memory and learning (SMD = 0.83, 95% CI 0.22 to 1.45, P = 0.008), visuospatial ability (MD = 3.15, 95% CI 0.74 to 5.56, P = 0.01), executive functions (MD = 0.32, 95% CI 0.03 to 0.61, P = 0.03), and physical activity (MD = 18.78, 95% CI 10.80 to 26.76, P < 0.00001). However, no significant benefit was found for TC on psychological activity (MD = 0.17, 95% CI ‐0.62 to 0.96, P = 0.36) and biomarker improvement. Conclusion. The meta‐analysis confirmed the clinical therapeutic effect of TC for MCI. More rigorous and long‐term follow‐up RCTs should be conducted in the future.

14 August 2019 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
FHFan Huang
Fan Huang
YXYumin Xie
Yumin Xie
SZSiyi Zhao
Siyi Zhao
ZFZitong Feng
Zitong Feng
GCGuizhen Chen
Guizhen Chen
YXYunxiang Xu
Yunxiang Xu
Purpose. To evaluate the effectiveness and safety of acupoint catgut embedding therapy (ACET) in postmenopausal osteoporosis (PMOP). Methods. Review of some databases from their inception to June 2018 and randomized controlled trials (RCTs) in which ACET with PMOP were included. Two researchers extracted and evaluated the information independently. Cochrane Collaboration’s tool and Jadad scale were used to evaluate the quality of the studies. RevMan V.5.3.3 software was used to carry out the meta-analysis while trial sequential analysis (TSA) performed with TSA 0.9 software. Results. 12 RCTs with 876 participants were included in this review. Meta-analysis showed that ACET alone was not superior to medication in effectiveness rate (RR= 1.11; 95% CI (0.89, 1.40); P=0.35) and E2 (SMD= 0.20; 95% CI (-0.17, 0.57); P=0.28; I2=20%) while ACET combining medication was more effective on the effectiveness rate (RR= 1.32; 95% CI (1.20, 1.46); P<0.000 01) and E2 (SMD= 1.24; 95% CI (0.63, 1.84); P<0.0001). Additionally, ACET combining calcium could increase the bone mineral density (BMD) of the L2~4 vertebrae and femur-neck [WMDL2~4 = 0.03; 95% CI (0.01, 0.05); P=0.003; and WMDFemur-neck = 0.07; 95% CI (0.03, 0.10); P = 0.0006], reduce TCM syndrome score [WMD = -1.85; 95% CI (-2.13, -1.57); P<0.000 01], improve patient’s quality of life [WMDthree  months = 6.90; 95% CI (3.90, 9.89); P<0.000 01; and WMDsix  months = 12.34; 95% CI (5.09, 19.60); P=0.0009], and relieve pain [WMDVAS = -1.26; 95% CI (-1.66, -0.85); P<0.000 01; and WMDPain  score = -2.59; 95% CI (-4.76, -0.43); P= 0.02]. The TSA showed that the effectiveness of ACET for PMOP was demonstrated accurately. Conclusions. ACET combining medication but not ACET alone is more effective than medication as comparison in the treatment of PMOP. As a novel treatment, ACET shows the potential of effectiveness and deserves further high quality of well-designed study.